ResearcherThomas Jefferson UniversityActive in the last 2 years
Alex O. Haber
Matched on OpenAlex author ID A5079153587. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress. Co-author DOI 10.1080/15384047.2024.2421584↗
- AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhibition. Co-author DOI 10.1158/1541-7786.mcr-20-0985↗
- Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Co-author DOI 10.1158/1541-7786.mcr-19-0589↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonathan Robert Brody · 3 shared papers, 2019–2024 · strength 0.40
- Paper The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through inc… DOI 10.1080/15384047.2024.2421584↗
- Paper AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhib… DOI 10.1158/1541-7786.mcr-20-0985↗
- Paper Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. DOI 10.1158/1541-7786.mcr-19-0589↗
- Aditi Jain · 2 shared papers, 2019–2021 · strength 0.21
- Paper AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhib… DOI 10.1158/1541-7786.mcr-20-0985↗
- Paper Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. DOI 10.1158/1541-7786.mcr-19-0589↗
- Talia Golan · 2 shared papers, 2019–2021 · strength 0.21
- Paper AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhib… DOI 10.1158/1541-7786.mcr-20-0985↗
- Paper Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. DOI 10.1158/1541-7786.mcr-19-0589↗
- Charles J. Yeo · 2 shared papers, 2019–2021 · strength 0.21
- Paper AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhib… DOI 10.1158/1541-7786.mcr-20-0985↗
- Paper Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. DOI 10.1158/1541-7786.mcr-19-0589↗
- Gordon Brent Mills · 1 shared paper, 2024 · strength 0.19
- Jennifer M. Finan · 1 shared paper, 2024 · strength 0.19
- Grace A. McCarthy · 1 shared paper, 2024 · strength 0.19
- Rosalie C. Sears · 1 shared paper, 2024 · strength 0.19
- Avinoam Nevler · 1 shared paper, 2021 · strength 0.13
- Teena Dhir · 1 shared paper, 2019 · strength 0.08
- Christopher William Schultz · 1 shared paper, 2019 · strength 0.08
- Liang Xu · 1 shared paper, 2019 · strength 0.08
- Samantha Z. Brown · 1 shared paper, 2019 · strength 0.08
- Chunhua Xi · 1 shared paper, 2019 · strength 0.08
- James A. Posey · 1 shared paper, 2019 · strength 0.08
- Gloria Huei-Ting Su · 1 shared paper, 2019 · strength 0.08
- Michael Jon Pishvaian · 1 shared paper, 2019 · strength 0.08
- Wei Jiang · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.